{"id":"W4323352826","doi":"10.1200/jco.22.01972","title":"MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Medical Research Council; Cancer Research UK","keywords":"Medicine; Ruxolitinib; Myelofibrosis; Discontinuation; Internal medicine; Gastroenterology; Cohort; Clinical endpoint; Surgery; Clinical trial; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006148613,0.0003063453,0.0006864684,0.0002503848,0.000176776,0.0004510919,0.0002769642,0.000249814,0.002806896],"category_scores_gemma":[0.000457988,0.0001372081,0.0003441215,0.000194891,0.0002021448,0.0003576805,0.0002269423,0.0007423243,0.0004362766],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003498486,"about_ca_system_score_gemma":0.0003313649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002140034,"about_ca_topic_score_gemma":0.001054619,"domain_scores_codex":[0.9998198,0.00006978468,0.00002394839,0.00002867953,0.00002823318,0.00002957641],"domain_scores_gemma":[0.9997953,0.00002809588,0.00007458172,0.00001495537,0.00001249582,0.00007462071],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1550476,0.01222263,0.03557705,0.002149392,0.0009413186,0.001143068,0.0002796996,0.002350744,0.06066376,0.0007395466,0.01174144,0.7171437],"study_design_scores_gemma":[0.2881838,0.4221643,0.1913755,0.0009548616,0.001821917,0.007644625,0.0003234113,0.005992181,0.02503679,0.001359571,0.05501718,0.0001258692],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9786173,0.01430706,0.0006329733,0.0006915107,0.0001057794,0.0005224253,0.0006475356,0.0002143216,0.004260972],"genre_scores_gemma":[0.9941593,0.002527109,0.0007152268,0.0004130901,0.0001113042,0.0002094425,0.0006614483,0.000009124009,0.001194009],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002806896,"threshold_uncertainty_score":0.009389997,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1404993595302603,"score_gpt":0.4583511375790651,"score_spread":0.3178517780488048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}